EE511 Cost Effectiveness of Uroprotective Agents for Cyclophosphamide and Ifosfamide Induced Hemorrhagic Cystitis in Childhood Cancers
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.753
https://www.valueinhealthjournal.com/article/S1098-3015(22)02957-6/fulltext
Title :
EE511 Cost Effectiveness of Uroprotective Agents for Cyclophosphamide and Ifosfamide Induced Hemorrhagic Cystitis in Childhood Cancers
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02957-6&doi=10.1016/j.jval.2022.09.753
First page :
Section Title :
Open access? :
No
Section Order :
10296